LAS VEGAS, Oct. 28 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells to families nationwide and internationally, is pleased to announce a new work agreement with the Hawaii Medical Service Association (HMSA), an independent licensee of the Blue Cross and Blue Shield Association, the largest and most experienced provider of health care coverage in Hawaii.
"Over half of Hawaii's population has chosen HMSA for their health care coverage," said Matthew Schissler, Chairman, CEO and co-founder of Cord Blood America. "We are pleased to work with such a prestigious, well-known and well-respected health care program."
HMSA is now offering their members the opportunity to bank their baby's cord blood, which contains important stem cells, privately at a generous discount. Members can also take advantage of Cord Blood America's "Afford-A-Cord" program, which allows for a smaller payment at time of birth.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit www.cordblood-america.com/.
E & E Communications
SOURCE Cord Blood America, Inc.